Yea SS[au] - Search Results

Year	Number of Results
1998	2
1999	1
2000	4
2001	3
2003	1
2005	4
2006	5
2007	5
2008	9
2009	4
2010	4
2011	2
2012	1
2013	3
2014	3
2015	2
2018	1
2019	2
2024	0

1

Achieving cancer cell death with PI3K/mTOR-targeted therapies.

Yea SS, Fruman DA. Yea SS, et al. Ann N Y Acad Sci. 2013 Mar;1280(1):15-8. doi: 10.1111/nyas.12028. Ann N Y Acad Sci. 2013. PMID: 23551096 Free PMC article. Review.

2

Cell signaling. New mTOR targets Grb attention.

Yea SS, Fruman DA. Yea SS, et al. Science. 2011 Jun 10;332(6035):1270-1. doi: 10.1126/science.1208071. Science. 2011. PMID: 21659593 No abstract available.

3

Secretome profiling of PC3/nKR cells, a novel highly migrating prostate cancer subline derived from PC3 cells.

Jeon JM, Kwon OK, Na AY, Sung EJ, Cho IJ, Kim M, Yea SS, Chun SY, Lee JH, Ha YS, Kwon TG, Lee S. Jeon JM, et al. Among authors: yea ss. PLoS One. 2019 Aug 12;14(8):e0220807. doi: 10.1371/journal.pone.0220807. eCollection 2019. PLoS One. 2019. PMID: 31404090 Free PMC article.

4

Selective inhibition of phosphoinositide 3-kinase p110α preserves lymphocyte function.

So L, Yea SS, Oak JS, Lu M, Manmadhan A, Ke QH, Janes MR, Kessler LV, Kucharski JM, Li LS, Martin MB, Ren P, Jessen KA, Liu Y, Rommel C, Fruman DA. So L, et al. Among authors: yea ss. J Biol Chem. 2013 Feb 22;288(8):5718-31. doi: 10.1074/jbc.M112.379446. Epub 2012 Dec 28. J Biol Chem. 2013. PMID: 23275335 Free PMC article.

5

A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice.

Choi JH, Kim KH, Roh KH, Jung H, Lee A, Lee JY, Song JY, Park SJ, Kim I, Lee WS, Seo SK, Choi IW, Fu YX, Yea SS, Park S. Choi JH, et al. Among authors: yea ss. Oncoimmunology. 2018 Jan 16;7(5):e1421890. doi: 10.1080/2162402X.2017.1421890. eCollection 2018. Oncoimmunology. 2018. PMID: 29721370 Free PMC article.

6

Effects of novel isoform-selective phosphoinositide 3-kinase inhibitors on natural killer cell function.

Yea SS, So L, Mallya S, Lee J, Rajasekaran K, Malarkannan S, Fruman DA. Yea SS, et al. PLoS One. 2014 Jun 10;9(6):e99486. doi: 10.1371/journal.pone.0099486. eCollection 2014. PLoS One. 2014. PMID: 24915189 Free PMC article.

7

Amplification of an RNA ligase ribozyme under alternating temperature conditions.

Kim KS, Oh S, Yea SS, Yoon MY, Kim DE. Kim KS, et al. Among authors: yea ss. FEBS Lett. 2008 Aug 6;582(18):2745-52. doi: 10.1016/j.febslet.2008.07.013. Epub 2008 Jul 14. FEBS Lett. 2008. PMID: 18625231 Free article.

8

Constituents of Corydalis heterocarpa and their anti-proliferative effects on human cancer cells.

Kim YA, Kong CS, Yea SS, Seo Y. Kim YA, et al. Among authors: yea ss. Food Chem Toxicol. 2010 Feb;48(2):722-8. doi: 10.1016/j.fct.2009.12.002. Epub 2009 Dec 21. Food Chem Toxicol. 2010. PMID: 20026161

9

Caffeic acid phenethyl ester inhibits the inflammatory effects of interleukin-1β in human corneal fibroblasts.

Yang JW, Jung WK, Lee CM, Yea SS, Choi YH, Kim GY, Lee DS, Na G, Park SG, Seo SK, Choi JS, Lee YM, Park WS, Choi IW. Yang JW, et al. Among authors: yea ss. Immunopharmacol Immunotoxicol. 2014 Oct;36(5):371-7. doi: 10.3109/08923973.2014.953957. Epub 2014 Aug 25. Immunopharmacol Immunotoxicol. 2014. PMID: 25151996

10

Genetic polymorphism of CYP2C9 in a Vietnamese Kinh population.

Lee SS, Kim KM, Thi-Le H, Yea SS, Cha IJ, Shin JG. Lee SS, et al. Among authors: yea ss. Ther Drug Monit. 2005 Apr;27(2):208-10. doi: 10.1097/01.ftd.0000153402.91854.42. Ther Drug Monit. 2005. PMID: 15795654

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

50 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year